- Mesothelioma news are updated once a hour
- We deliver news from more than 500 sources on mesothelioma
NewsAdvertisers: |
Widower remembers wife's struggle through foundation... He began to wonder if there was any connection between Brenda's sexual abuse and cancer diagnosis, along with various other health problems she had dealt with over the years. Through his research, Kroeger said he discovered 26 physical, psychological and social problems linked to sexual abuse. This includes 12 actual physical diseases such as cancer and diabetes. (The others, along with references, are listed on the foundation's website at www.stopsexualabusenow.org.) One resource Kroeger found particularly helpful was The Link between Religious and Health, edited by Harvey J. Cohen and Harold Koenig, medical researchers at Duke University. The book refreshed his knowledge, Kroeger explained, on the link between stress and illness. "I realize there have only been a few studies showing an increased risk of cancer for survivors of sexual abuse, but I think many other problems associated with this trauma establish sexual abuse as one of America's most pressing health issues," he said. "Between 25 to 30 percent of women are survivors and 10 to 15 percent of men, which is probably under-reported. Perhaps once the stigma and taboo is lifted, survivors will become more willing to share such information." He established the Foundation for the Healing for Survivors of Sexual Abuse last su... Asbestos caused Navy veteran's death...
body {background: #FFFFFF;margin: 0px 0px 0px 0px;padding: 0px 0px 0px 0px;font-family: tamoha, verdana, arial, sans-serif;}
.margin01 {margin: 12px;}
.margin02 {margin: 12px 0px 12px 12px;}
.margin03 {margin: 12px 0px 0px 12px;}
.arc_img {border: 1px solid #6699CC;}
.bg4a {background-color: #6699CC;}
.bg3d {background-color: #D1E3F2;}
.bg4d {background-color: #D1E3F2;}
.bg3e {background-color: #D1E2FE;}
.bg1d {background-color: #D1E3F2;}
.bg1a {background-color: #014E82;}
.bg1c {background-color: #6699CC;}
.bg1e {background-color: #FFFFFF;}
/* Main Content Column */
#news-heading {color: #FFFFFF;font-size:70%;font-weight: bold;text-decoration: none;background-color:#6699CC;}
#news-title {color: #014E82;font-size:70%;font-weight: bold;text-decoration: none;}
#news-title a {color: #014E82;font-weight:bold;text-decoration: none;}
#news-title a:hover {color: #014E82;font-weight:bold;text-decoration: underline;}
#news-body {color: #000000;font-size:70%;font-weight: normal;text-decoration: none;}
#news-body a {color: #014E82;font-weight:normal;text-decoration: none;}
#news-body a:hover {color: #014E82;font-weight:normal;text-decoration: underline;}
TD.newsbox {border-color:#6699CC;border-width:1px;border-style:solid;background-color:#F0F8FE;padding: 8px;}
TD.commentmain {border-color:#6699CC;border-width:1px;border-style:solid;background-color:#F0F8FE;padding: 2px; font-size:70%;font-weight:normal; color:#000000;text-decoration:... Researchers Identify Intracellular Pathway of Alfacell's Onconase... Safe Harbor This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release. Media Contact David Schull or Wendy Lau Noonan Russo 212-845-4271 Investor Contact: Andreas Marathovouniotis Noonan Russo 212-845-4253 david.schull@eurorscg.com wendy.lau1@eur... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news |